Premium
BK viremia is not associated with adverse outcomes in the absence of BK nephropathy
Author(s) -
HertzTang Amber L.,
Astor Brad C.,
Mandelbrot Didier A.,
Mohamed Maha A.,
Djamali Arjang,
Parajuli Sandesh
Publication year - 2018
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13283
Subject(s) - medicine , viremia , bk virus , transplantation , nephropathy , kidney transplantation , immunology , urology , endocrinology , antibody , diabetes mellitus
There are limited data regarding the association of different levels of BK viremia and BK nephropathy ( BKN ), and graft outcomes. We studied the BK plasma PCR levels of all kidney transplant recipients ( KTR ) transplanted at our institution between 01/01/2006 and 06/30/2014. Patients were divided into groups based on their highest BK plasma PCR level within the first year following transplantation: undetectable, low (<1000 copies/mL), moderate (1000‐10 000 copies/mL), high (>10 000‐100 000 copies/mL), very high (>100 000 copies/mL), and those that had biopsy‐proven BKN . There were a total of 1146 KTR during the study period: 813 with undetectable BK levels and 333 with any detectable BK level (87 with low, 79 with moderate, 88 with high, 34 with very high level BK , and 45 that had BKN ). Compared to KTR with an undetectable BK level, incidence of mortality, graft failure, rejections,and infections were not significantly different for those with low, moderate, high, or very high BK level. Patients with BKN had a higher rate of infection and higher rates of total graft failure or death‐censored graft failure compared to those with undetectable BK levels. BK viremia in the absence of BKN does not significantly increase the risk of rejection, infections, or graft failure compared to an undetectable BK level.